Considering the functional link suggested by the identification of PSIS patients with putatively pathogenic DCHS2 variants, we next sought to confirm such an implication using a Dchs2 mutant mouse model. This evidence concerns the gene DCHS2 and pituitary stalk interruption syndrome.